Building Quality into Advanced Therapies from Day One
March 13, 2026
Why early, risk-based thinking is critical in cell and gene therapy development
5 min read
False
Advertisement
Interviews
The New Blueprint for Vaccine Development
March 12, 2026
ReiThera’s leaders discuss platform technologies, scalable manufacturing, and the trust needed to strengthen global vaccine preparedness
5 min read
What Does Corporate Compliance Really Mean?
By Stephanie Vine
March 10, 2026
Corporate compliance isn’t just about avoiding fines; it’s an opportunity to shape culture, partnerships, and everyday decision-making
10 min read
Solving the Problem of Insolubility: Part III
March 3, 2026
Exploring new applications for KinetiSol and the evolving role of CDMOs in bringing the next generation of complex molecules to patients
4 min read
Human-Relevant Discovery: iPSC Models and the Future of Rare Disease R&D
February 25, 2026
A Q&A with iXCells Biotechnologies CEO, Steve Smith
8 min read
Solving the Problem of Insolubility: Part II
February 24, 2026
KinetiSol’s solvent-free mixing process turns “brick dust” drugs into stable amorphous dispersions
5 min read
Building an Integrated Discovery Engine
February 23, 2026
An Interview with Adam Davenport, CSO, Concept Life Sciences
4 min read
Building Better Oral Suspensions for Pediatric & Real-World Use
February 18, 2026
Greg Thomas, Kiel Laboratories’ Vice President of R&D, discusses oral suspensions, excipients, and patient-centered formulation
4 min read
Training the Medicine Makers the UK Can’t Afford to Lose
February 12, 2026
Why immersive training could be critical to closing the UK’s medicines manufacturing skills gap
4 min read
Industry News
Facilities & Equipment
Future of Pharma
Interviews
Business & Trends
Technology & Manufacturing
Sustainability Is the New Survival Strategy
January 21, 2026
Green issues shouldn’t be treated as “woke.” Instead, they should be seen as pharma’s license to operate. Three industry experts discuss.
10 min read
